CellCentric

Cellcentric is a clinical-stage company developing small molecule inhibitors of p300/​CBP to treat multiple myeloma and other various cancers.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2024
Cellcentric Portco Hover Image